Critical Review: Wetouch Technology (NASDAQ:WETH) versus Dominari (NASDAQ:DOMH)

Insider and Institutional Ownership

42.5% of Dominari shares are owned by institutional investors. 36.7% of Dominari shares are owned by company insiders. Comparatively, 25.3% of Wetouch Technology shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Risk and Volatility

Dominari has a beta of 0.96, meaning that its share price is 4% less volatile than the S&P 500. Comparatively, Wetouch Technology has a beta of -0.03, meaning that its share price is 103% less volatile than the S&P 500.

Valuation and Earnings

This table compares Dominari and Wetouch Technology”s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Dominari $12.59 million 0.57 -$22.88 million ($3.87) -0.29
Wetouch Technology $41.02 million 0.47 $8.26 million N/A N/A

Wetouch Technology has higher revenue and earnings than Dominari.

Profitability

This table compares Dominari and Wetouch Technology’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Dominari -180.22% -32.89% -29.47%
Wetouch Technology N/A N/A N/A

Summary

Wetouch Technology beats Dominari on 5 of the 9 factors compared between the two stocks.

About Dominari

(Get Free Report)

Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as AIkido Pharma Inc. and changed its name to Dominari Holdings Inc. in December 2022. Dominari Holdings Inc. was founded in 1967 and is headquartered in New York, New York.

About Wetouch Technology

(Get Free Report)

Wetouch Technology Inc. engages in the research, development, manufacture, sale, and servicing of medium to large sized projected capacitive touchscreens in the Peoples Republic of China, Taiwan, South Korea, and internationally. The company offers various touch panels, including glass-glass, which are primarily used in GPS/car entertainment panels in mid-size and luxury cars, industrial human-machine interface (HMI), financial and banking terminals, point of sale, and lottery machines; glass-film-film products that are used in GPS and entertainment panels, industrial HMI, financial and banking terminals, lottery, and gaming industry; plastic-glass for use in GPS/entertainment panels, motor vehicle GPS, smart home products, robots, and charging stations; and glass-films used in industrial HMI. Wetouch Technology Inc. was founded in 2011 and is based in Meishan, China.

Receive News & Ratings for Dominari Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dominari and related companies with MarketBeat.com's FREE daily email newsletter.